Hummelgaard Sandra, Weyer Kathrin
Department of Biomedicine, Faculty of Health, Aarhus University, Aarhus, Denmark.
Nephron. 2023;147(3-4):244-249. doi: 10.1159/000526369. Epub 2022 Sep 12.
The kidney proximal tubule is a major target tissue of the renin-angiotensin system (RAS). Megalin is an endocytic multiligand receptor abundantly expressed in the proximal tubule where it drives reabsorption of peptides and proteins from the glomerular ultrafiltrate. All major RAS components are present in the kidney proximal tubules. Here, megalin drives endocytosis of angiotensinogen (AGT), prorenin, and renin, while angiotensin-converting enzyme is localised at the brush border of the proximal tubule cells. Intrarenal formation of the key RAS effector angiotensin II (ANG II) occurs, and liver-derived AGT appears to be the primary source. New studies further suggest that megalin-mediated reabsorption of liver-derived AGT contributes to renal ANG II levels and thereby may influence renal RAS activity. This mini-review presents the recent advances on RAS in the proximal tubule and the involvement of megalin in the uptake and regulation of local RAS and discusses the possibility that megalin is involved in blood pressure regulation.
肾近端小管是肾素-血管紧张素系统(RAS)的主要靶组织。巨膜蛋白是一种内吞性多配体受体,在近端小管中大量表达,它驱动肾小球超滤液中肽和蛋白质的重吸收。所有主要的RAS成分都存在于肾近端小管中。在这里,巨膜蛋白驱动血管紧张素原(AGT)、肾素原和肾素的内吞作用,而血管紧张素转换酶定位于近端小管细胞的刷状缘。关键的RAS效应物血管紧张素II(ANG II)在肾内形成,肝脏来源的AGT似乎是主要来源。新的研究进一步表明,巨膜蛋白介导的肝脏来源AGT的重吸收有助于肾脏ANG II水平,从而可能影响肾脏RAS活性。这篇小型综述介绍了近端小管中RAS的最新进展以及巨膜蛋白在局部RAS的摄取和调节中的作用,并讨论了巨膜蛋白参与血压调节的可能性。